Basic Information
Our Business
Approach to Corporate Activities
Corporate Activity Policy and Plans
Performance Products
Industrial Materials
Health Care
Our Research & Development
Corporate Venture Activity
To Our Investors
IR News
To Our Individual Investors
IR Calendar
Sustainability Activities
ESG Initiatives
Sustainability Data
Feb. 24, 2023
Sep. 27, 2022
Dec. 1, 2021
Mar. 3, 2021
Feb. 25, 2021
Feb. 12, 2020
Nov. 18, 2019
May 30, 2019
Dec. 4, 2018
Nov. 28, 2017
Dec. 8, 2016
Dec. 9, 2015
Mar. 11, 2015
Jun. 9, 2014
Dec. 12, 2013
Mar. 05, 2013
Jun. 12, 2012
APTSIS 15 Current Status
Dec. 8, 2011
Jun. 14, 2011
Dec. 8, 2010
The Mitsubishi Chemical GroupMid-term Management Plan, APTSIS 15
Jun. 1, 2010
APTSIS 10 Current Status
Nov. 19, 2009
Briefing regarding Management Integration
Jun. 2, 2009
Dec. 9, 2008
May 13, 2008
The Mitsubishi Chemical GroupMid-term Management Plan, APTSIS 10
May 31, 2007
Preliminary Presentation of the New Mid-term Management Plan 'Good Chemistry for Tomorrow' Towards 2025
May 16, 2007
Briefing on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation
Feb. 8, 2007
The Restructuring and Consolidation of the Functional Products Businesses of the Mitsubishi Chemical Group and a Tender Offer for Shares of Mitsubishi Plastics, Inc.
Nov. 21, 2006
Performance and Functional Products Segment - High-Value-Added Businesses -
May. 31, 2006
Petrochemicals Segment - Business Perspective and Strategy -
Jan. 18, 2006
Health Care Segment - Personalized Medicine for Tomorrow -
